In contrast, higher titres of some tumour‐infiltrating immune cells, such as CD4+ helper T cells, CD8+ cytotoxic T cells, natural killer (NK) cells and dendritic cells are associated with more favourable treatment outcomes and improved prognosis due to their ability to attack and destroy cancer cells.20 This evidence concerns the gene CD4 and neoplasm.